Evidence map

ReviewFrontiers in endocrinology2025

Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions.

Yuliya Tseyslyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41255540